In this cohort, RB1CC1(−) status correlated significantly with PR-negative and triple-negative phenotypes, as well as chemotherapy, and these findings seem to be closely related because chemotherapy was often applied to the PR-negative and/or triple-negative breast cancer patients. This evidence concerns the gene PGR and triple-negative breast carcinoma.